Malaria eradication in an age of artemisinin resistance: an African perspective

WWARN Published Date

Tuesday 8th October 15:00 - 16:30 Room 22

Chair: Philippe Guérin; Co-chair Ben Andagalu

Other Panelists: Issaka Sagara, Bernhards Ogutu, Ambrose Talisuna and Christian Nsanzabana

The recognition of diminished efficacy of artemisinins in Southeast Asia has increased the pressure to track the treatment efficacy of artemisinin-combination therapies (ACTs) in Africa.  Although the overall clinical efficacy of ACTs remains high in Africa, we need to devise and adopt approaches that will allow detection of early signs of resistance to either artemisinins or their partner drugs, amodiaquine, lumefantrine and piperaquine. In this symposium, we will explore approaches that can provide us with an early warning of diminished efficacy of ACTs, and discuss together how these can be implemented in a variety of African settings.

WWARN invites you to a drinks reception

Join us Thursday 10th October 6.30pm -8.00pm at the Polo Club Bar, Hilton Hotel (ground floor).

Download and print our MIM 2013 Programme

Other symposia WWARN colleagues are supporting

Field monitoring of malaria drug efficacy and safety

Monday 7th October 9:30-11:00 Room 22 / Symposium 4

Chair : Godwin Ntadom; Co-Chair: Philippe Guérin 

Other Panelists:Ambrose Talisuna and Wilfred Mbacham

 

The role of vaccines in malaria elimination

Tuesday 8th October 08:00-9:30 Room 22 / Symposium 20

Chair: Chris Plowe; Co-chair: Marcel Tanner

Other panelists: Edward Wenger and Stephen Hoffman

 

Tracking Artemisinin Resistance 

Tuesday 8th October 17:00-18:30 Room 12 / Symposium 34

 

Seasonal Malaria Chemoprevention: the broader picture

Tuesday 8th October 17:00-18:30 Hall 4B / Symposium 36

Chair: Chris Plowe; Co-chair: Martin De Smet

Other Panelists: Jean Louis Ndiaye, Alex Doodo, Alassane Dicko and Chris Drakeley

 

WWARN Exhibit Stand 48. 

Our stand 48 will highlight the results of our Scientific Study Groups,  including their findings from treatement eficacy and dosing studies, and showcase the WWARN Toolkit – a portfolio of essential tools and services for investigators carrying out research on malaria drug resistance. The toolkit includes training courses, data management and analysis tools, standard operating procedures and QA/QC programmes for associated laboratory tests. WWARN’s Toolkit is free to use – visit our stand to view the tools.

When: During break sessions 11.00-11.30am and 3.30-4.00pm from 6th-11th October 

Download and print our MIM 2013 Programme. See the full MIM 2013 Symposia programme, and the MIM 2013 conference website.